A low signed-case price can hide weak cases, heavy fallout, or missing medical records. A higher price might actually produce better margins once you account for validation and compensability. Pricing varies by tort, claimant eligibility rules, injury profile, ad channel, geography, and whether a quote covers a lead, a signed retainer, or a fully validated case.
This guide breaks down current pricing research, the real cost components behind a "signed case," the factors that move pricing, and a budgeting framework that separates apparent acquisition cost from true cost per compensable case.
Key Takeaways
- Reject any mass tort cost figure not tied to a specific tort, date, source, and qualification standard.
- Track cost per qualified, retained, compensable, and resolved case, not only signed retainers.
- Medical records, case development, engagement, and fallout raise true acquisition cost.
- Cheap quotes lose once compliance, transparency, and downstream conversion enter the math.
How Much Does a Mass Tort Case Cost? (Pricing Overview)
There's no fixed national price for a mass tort case, signed or otherwise. Quotes shift fast as litigation status changes, advertiser competition rises or falls, and eligibility criteria get updated by judges or review panels.
Much of the confusion comes from mixing up metrics that sound alike but measure different outcomes:
| Metric | What it measures |
|---|---|
| Cost per lead | Amount paid for an initial inquiry or contact |
| Cost per signed retainer | Amount spent to get a claimant to sign representation paperwork |
| Cost per qualified/compensable case | Spend after accounting for eligibility, evidence, and medical documentation |
| Cost per resolved claim | Total acquisition and downstream cost divided by cases that actually produce a recovery |
Current paid-channel benchmarks
On paid mass tort channels, typical cost per lead runs $1,500 to $3,000, with cost per click landing between $200 and $500+, depending on the tort and competition level. Those figures are lead-cost benchmarks, not signed-case prices, and they move with market demand.
How fast pricing can shift
Bloomberg Law reported that the price of a purchased Camp Lejeune claim rose from roughly $1,000 before the relevant legislation passed to $5,000 or more afterward. Purchased-case prices keep adjusting as advertiser participation and litigation developments change. That 2023 snapshot covers one tort at one moment — not a current industry benchmark.
What a quoted price may or may not include:
- Advertising and creative production
- Intake, call handling, and retainer execution
- Preliminary screening questions
- Medical-record retrieval and case development
- Case-management technology and quality assurance
- Refund or replacement-case policies
Misreading what's covered causes real problems. Firms often:
- Underbudget the full path from lead to signed case
- Accept weak cases to hit volume targets
- Overlook downstream fallout costs
- Scale campaigns before conversion data is reliable
Each of those mistakes compounds once you're running at volume.
Key Factors That Affect the Cost Per Signed Mass Tort Case
Price reflects both market demand and how much screening, documentation, and compliance work it takes to produce a usable case. A few variables drive most of the swing.
Type, Stage, and Complexity of the Mass Tort
Litigation stage changes everything. Early-stage torts with limited public awareness often cost less per lead but carry more uncertainty about eligibility criteria. Highly competitive, actively advertised torts — the kind with dozens of firms bidding on the same keywords — tend to push acquisition costs up fast.
Mature or declining dockets may see falling demand, while newly reopened eligibility windows can spike competition overnight. None of this predicts settlement value; it only reflects how many firms are chasing the same claimant pool.
Injury Profile and Qualification Requirements
Cases requiring a specific diagnosis, documented exposure duration, product identification, or proof of surgery need far more screening than broad-interest claims. Federal Judicial Center guidance on MDL plaintiff fact sheets confirms this: claimant-specific product-use, injury, and medical-history documentation is standard in multidistrict proceedings. Validation work is baked into the process, not optional.
Unclear claimant histories, missing records, and duplicate representation all increase fallout after the retainer gets signed.
Marketing Channel and Lead Source
Channel choice affects intent and quality as much as cost:
- Television and broad social media — high reach, variable intent, often lower qualification rates
- Paid search — stronger intent since users are actively searching, but expensive per click
- Referrals — smaller volume but historically higher quality and conversion
- Third-party lead vendors — volume on demand, but service scope (call handling, record retrieval) varies by vendor
Track contact rate, signed-retainer rate, validation rate, and fallout rate by source. A channel with a low cost per lead but high fallout can quietly cost more per compensable case than a pricier source.
Intake, Screening, and Case Development
Investments that raise cost at signing also cut attrition later:
- Fast response times
- Trained intake staff
- Layered qualification questions
- Upfront consent documentation
Know which of these your vendor quote actually covers. Intake labor, record collection, and quality control are often billed separately from the lead or retainer price itself.
Competition, Geography, and Capacity
National campaigns compete against every firm running the same tort simultaneously. State-specific targeting can reduce competition but also shrinks available claimant volume. Language access, local media rates, and your own intake capacity all factor into what you'll actually pay, and whether you can handle the volume once you're paying for it.
Cost Breakdown of a Signed Case and Low-Cost vs High-Cost Acquisition
A signed-retainer price is one line item in a much larger cost structure. The full cost stack usually looks like this:
| Cost component | Timing | What it covers |
|---|---|---|
| Acquisition and intake | One-time, per lead or retainer | Media, lead-gen fees, call handling, intake labor, consent capture |
| Case validation and development | Milestone-based | Medical-record retrieval, exposure verification, authorizations, lien-related work |
| Claimant engagement and fallout | Recurring | Outreach, status updates, duplicate checks, cost of unreachable or ineligible claimants |
| Funding, staffing, and vendor terms | Recurring/periodic | Internal staff time, software, financing costs, refund and replacement-case terms |
The MTVA's industry guidelines specifically direct buyers to ask vendors what a quoted price includes and how they handle non-qualified leads or retainers before signing a contract. Ask it before you sign. That one question is what separates a predictable campaign from a costly surprise.
Upfront price alone misleads. Source quality shows up later:
- Lower-cost sources: Often look strong on a signed-case report, then show higher fallout, weaker intent, or incomplete documentation in validation
- Higher-cost sources: Earn the premium with stronger qualification, cleaner records, and better claimant engagement, which can lower cost per compensable or resolved case
The only fair comparison uses the same qualification definition, time period, tort, and service scope on both sides. Comparing a $2,000 lead-only quote against a $5,000 signed-and-validated quote tells you nothing useful.
How to Estimate the Right Budget for Mass Tort Case Acquisition
Set your budget from case criteria, intake capacity, and risk tolerance. The lowest signed-retainer quote is the wrong anchor.
Build a Funnel-Based Cost Model
Calculate cost separately at each stage: leads, signed retainers, validated cases, compensable cases, and resolved claims. Hypothetical figures below are for illustration only:
A firm spends $150,000 on a monthly mass tort campaign and generates:
- 75 leads at $2,000 cost per lead
- 30 signed retainers → $5,000 cost per signed case
- 20 validated cases after fallout → $7,500 cost per validated case
- 15 compensable cases meeting eligibility criteria → $10,000 cost per compensable case
- 10 resolved claims over time → $15,000 cost per resolved claim
True cost triples from lead to resolved claim. If you only track cost per signed case, that gap stays hidden until spend is already locked in.
Set Measurement Standards Before Buying
Before spending a dollar, define reporting fields in writing:
- Source, campaign, tort, and state
- Consent and contact status
- Retainer status and qualification outcome
- Record status, fallout reason, refund, and resolution
Also agree on attribution windows, duplicate handling, and audit rights with any vendor upfront.
Stress-Test the Campaign
Model conservative, expected, and optimistic scenarios using your own historical conversion data, not vendor projections. Then check capacity honestly:
- Do you have enough intake staff for the projected volume?
- Can attorneys review cases fast enough to avoid bottlenecks?
- Is records support adequate for the expected validation workload?
Evaluate a Legal Marketing Partner
Running paid intake, SEO, and vendor relationships at once usually needs one system, not a patchwork of disconnected vendors.
LEXGRO's fractional CMO work tracks leads from first click through signed retainer and reports cost per signed case by channel. That visibility helps firms catch fallout patterns before they scale a losing campaign. Treat it as one option to evaluate — not a promise of specific mass tort pricing or results.
What Most Firms Miss When It Comes to Cost
- Cost per signed case gets tracked; cost per validated or compensable case does not
- Vendor averages get treated as guarantees without tort, date, and qualification checks
- Consent, duplicate representation, and data-security duties get skipped in the rush to buy volume
- Spend scales before the data shows whether marketing or intake is driving fallout
Conclusion
Mass tort cost per signed case is a moving market figure, not a fixed price tag or a standalone measure of profitability. Firms that treat it as one input among several, alongside qualification quality, downstream costs, fallout, and compliance, make sharper acquisition decisions.
Before committing real budget:
- Validate current market data for your practice area and case type
- Push vendors for transparent terms on qualification, pricing, and fallout
- Test campaigns against your own documented performance, not industry averages
Frequently Asked Questions
How much is a mass tort settlement?
Settlement amounts vary by tort type, injury severity, proof of causation, and eligibility rules. Fees, liens, allocation methods, and litigation posture also change the final payout, so no single figure applies across cases.
What is the average cost per signed mass tort case?
No universal average exists for signed cases. Paid mass tort leads often run $1,500 to $3,000, while signed-case pricing depends on the tort, timing, market, and qualification standard used.
What is the difference between cost per lead and cost per signed case?
Cost per lead measures the price of an initial inquiry, while cost per signed case reflects the spend needed to get a claimant to execute representation paperwork. Neither metric alone indicates case quality or eventual profitability.
Why can a low-cost mass tort case be more expensive in the long run?
Cheaper sources often carry more fallout, missing medical records, or duplicate representation that surfaces during validation. That extra screening, staffing, and re-engagement work often pushes the true cost well above a higher-priced but cleaner source.
How should a law firm compare mass tort lead vendors?
Compare source transparency, qualification standards, consent documentation, historical fallout rates, refund terms, and reporting access. Ask for references and confirm exactly what the quoted price includes before signing.
What metric is better than cost per signed mass tort case?
Track cost per qualified, compensable, and resolved case alongside signed-retainer cost. Clear definitions for each stage show true campaign profitability far better than signed-case cost alone.
